Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New betulin acid derivatives discovered at Hetero Labs

Sep. 7, 2020

Purdue University compounds are active against vancomycin-resistant enterococcus

Sep. 7, 2020

Clear Creek Bio starts phase I study of brequinar for treatment of COVID-19

Sep. 4, 2020

Savara ends exploratory study of Molgradex for nontuberculous mycobacterial lung infection in CF

Sep. 4, 2020

City of Hope tests leflunomide in cancer patients with COVID-19

Sep. 4, 2020

ESsCOVID study of trimodulin in patients with COVID-19 receives approval in Spain

Sep. 4, 2020

New phase II study evaluates inhaled ensifentrine in hospitalized patients with COVID-19

Sep. 4, 2020

Health Canada clears initiation of phase III trial of Pulmonem's reformulated dapsone for COVID-19

Sep. 3, 2020

Janssen discontinues development of pimodivir for influenza A

Sep. 3, 2020

Starpharma creates long-acting, water-soluble version of remdesivir

Sep. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...